about
COST Action ES1403: New and Emerging challenges and opportunities in wastewater REUSe (NEREUS)Spatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysisRemoval of residual pharmaceuticals from aqueous systems by advanced oxidation processes.Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research.Transformation products of pharmaceuticals in surface waters and wastewater formed during photolysis and advanced oxidation processes - degradation, elucidation of byproducts and assessment of their biological potency.Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: a review.Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: a review.Environmental side effects of pharmaceutical cocktails: what we know and what we should know.Treatment of winery wastewater by physicochemical, biological and advanced processes: a review.The environmental footprint of a membrane bioreactor treatment process through Life Cycle Analysis.Dissolved effluent organic matter: Characteristics and potential implications in wastewater treatment and reuse applications.The potential implications of reclaimed wastewater reuse for irrigation on the agricultural environment: The knowns and unknowns of the fate of antibiotics and antibiotic resistant bacteria and resistance genes - A review.Antibiotic resistance in urban aquatic environments: can it be controlled?Assessing the potential of pharmaceuticals and their transformation products to cause mutagenic effects: Implications for gene expression profiling.Two important limitations relating to the spiking of environmental samples with contaminants of emerging concern: How close to the real analyte concentrations are the reported recovered values?Chronic ecotoxic effects to Pseudomonas putida and Vibrio fischeri, and cytostatic and genotoxic effects to the hepatoma cell line (HepG2) of ofloxacin photo(cata)lytically treated solutions.High Throughput Analysis of Integron Gene Cassettes in Wastewater Environments.On the capacity of ozonation to remove antimicrobial compounds, resistant bacteria and toxicity from urban wastewater effluents.Investigating the fate of iodinated X-ray contrast media iohexol and diatrizoate during microbial degradation in an MBBR system treating urban wastewater.Erythromycin oxidation and ERY-resistant Escherichia coli inactivation in urban wastewater by sulfate radical-based oxidation process under UV-C irradiation.Pharmaceuticals and illicit drugs in wastewater samples in north-eastern Tunisia.Novel approach to fast determination of cholesterol oxidation products in Cypriot foodstuffs using ultra-performance liquid chromatography-tandem mass spectrometry.Dental solid and hazardous waste management and safety practices in developing countries: Nablus district, Palestine.Solar Fenton and solar TiO2 catalytic treatment of ofloxacin in secondary treated effluents: evaluation of operational and kinetic parameters.Sonochemical degradation of ofloxacin in aqueous solutions.Applications of advanced oxidation processes in wastewater treatment.Assessment of long-term wastewater irrigation impacts on the soil geochemical properties and the bioaccumulation of heavy metals to the agricultural products.An alternative method for the treatment of waste produced at a dye and a metal-plating industry using natural and/or waste materials.Utilizing solar energy for the purification of olive mill wastewater using a pilot-scale photocatalytic reactor after coagulation-flocculation.A study on the attitudes and behavioural influence of construction waste management in occupied Palestinian territory.Solar photocatalytic treatment of trimethoprim in four environmental matrices at a pilot scale: transformation products and ecotoxicity evaluation.Solar photo-Fenton process on the abatement of antibiotics at a pilot scale: Degradation kinetics, ecotoxicity and phytotoxicity assessment and removal of antibiotic resistant enterococci.Sunlight, iron and radicals to tackle the resistant leftovers of biotreated winery wastewater.Superiority of solar Fenton oxidation over TiO2 photocatalysis for the degradation of trimethoprim in secondary treated effluents.Is the evaluation of "traditional" physicochemical parameters sufficient to explain the potential toxicity of the treated wastewater at sewage treatment plants?Wastewater reuse applications and contaminants of emerging concern.Treatment efficiency and economic feasibility of biological oxidation, membrane filtration and separation processes, and advanced oxidation for the purification and valorization of olive mill wastewater.Transformation products and reaction pathways of carbamazepine during photocatalytic and sonophotocatalytic treatment.Reduction of clarithromycin and sulfamethoxazole-resistant Enterococcus by pilot-scale solar-driven Fenton oxidation.Ultraviolet-activated persulfate oxidation of methyl orange: a comparison between artificial neural networks and factorial design for process modelling.
P50
Q29014403-A0E2C418-D996-42D7-96BC-8FFB05B65025Q34376086-766FECDA-5F95-4DE7-93E8-E8149E4B900CQ37257226-1AFA140A-86AA-4403-A7B1-2CBDD9D87466Q37808368-4E6E77C5-F754-44E1-9390-DB78448BCE61Q37915747-A2DBCB94-5D04-40A3-B614-5B0340DFBF72Q38069740-DC4B0D7E-0BFC-418B-9953-26C583B9E30FQ38080393-4BD5742E-D245-4333-B3D8-8EE4ED944DB0Q38233911-11126602-D74F-4755-8844-399F66A10C4FQ38337734-C276BF48-518A-4C2B-8D9D-1B00F6D17E20Q38379595-CD96FF6E-C94A-4D8B-BD20-C0478A0A181FQ38445027-147C63C1-0851-4C4C-B55B-7E1D389D13A1Q38660899-A55A0AE7-57E9-4C23-A464-152B54CEDD86Q38663700-90BDF1F3-D3ED-40A8-A880-C980EC3ABF90Q38737969-C4AC760D-FFAE-447D-AC10-45F07FC670A9Q38775510-BF4F63A9-56E5-4ABD-981C-9A79756E9FB1Q39323427-FFFCCB37-CFBE-45E9-9F73-F1319BC10947Q39334619-58561316-A704-474E-BEAB-5FA331DC0E11Q39944412-358B1DEC-1A14-4092-BBFC-720BD1088D69Q40101015-33B7E713-798E-486B-A30E-FFCAB3B34835Q40312323-C3DEEF9B-128A-4DB5-9221-855350E5B667Q40459714-CB8232AF-402A-4A2D-8BF5-4D2736650DD8Q40580668-B3911419-45DB-485A-8555-08A10BB4C996Q42633508-3EEEB576-34E0-49F6-B3A7-F84D44A909A5Q42953506-A866BEAD-45A5-40A7-BCB0-22F75A04CFC4Q43016509-27BBA054-B8D5-4E9C-8F93-25A3C24097CBQ43309448-C62A9576-8017-425C-BB2D-4E59036B0498Q43315275-D3F039B9-7017-4930-82D6-D0EDA1B8E886Q43315307-419A8E91-F869-4403-AD05-4146FE3C2CB6Q43317420-29306EDC-7810-49D8-B6D4-9CE95697BB83Q43334850-2A173817-4547-4F79-97AB-C9ABB0B2113DQ43344791-12820887-177E-4BAE-B5D4-AA769623A26BQ43348241-9112A7BD-B739-4ACD-8BFE-BEEBD08C2211Q43350624-18AFACF9-D4BD-41AC-A7FC-AF9DE9443644Q43356304-756A8062-2A4E-4F94-A4A0-40B36FC53773Q43356698-36706708-7770-49A2-AD35-F546C23F0531Q43357955-0B2EDCF5-8BB7-425D-A99C-D258EFF0964FQ43359950-E349CD05-D766-4BAD-B341-C81D68CC7F06Q43362794-CDBC5674-FCD4-4CD9-A51E-1A24D49B22B3Q43363356-04CE4D38-1342-431A-9826-C36083C18DC1Q44442454-54598618-2AF3-4F05-A6ED-DEFCB1DDFC22
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Despo Fatta-Kassinos
@ast
Despo Fatta-Kassinos
@en
Despo Fatta-Kassinos
@es
Despo Fatta-Kassinos
@nl
Despo Fatta-Kassinos
@sl
type
label
Despo Fatta-Kassinos
@ast
Despo Fatta-Kassinos
@en
Despo Fatta-Kassinos
@es
Despo Fatta-Kassinos
@nl
Despo Fatta-Kassinos
@sl
altLabel
DESPO FATTA
@en
DESPO KASSINOS
@en
prefLabel
Despo Fatta-Kassinos
@ast
Despo Fatta-Kassinos
@en
Despo Fatta-Kassinos
@es
Despo Fatta-Kassinos
@nl
Despo Fatta-Kassinos
@sl
P214
P1053
G-2331-2016
P106
P1153
6603838891
P21
P214
P31
P3829
P496
0000-0003-1173-0941
P7859
viaf-1234011